Analysis Metabolite Name Measured Value Units Sample description Tissue
Reversed phase POSITIVE ION MODESarcosine0.479uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine0.507uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine0.54uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine0.541uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine0.553uMA375 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine0.557uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine0.568uMWM47 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine0.57uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine0.603uMA375 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine0.606uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine0.612uMWM47 LCT tumor
Reversed phase POSITIVE ION MODESarcosine0.622uMWM47 LCT tumor
Reversed phase POSITIVE ION MODESarcosine0.634uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine0.635uMWM47 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine0.636uMWM47 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine0.646uMWM47 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine0.661uMA375 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine0.669uMWM47 LCT tumor
Reversed phase POSITIVE ION MODESarcosine0.683uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine0.692uMWM47 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine0.695uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODESarcosine0.711uMA375 LCT tumor
Reversed phase POSITIVE ION MODESarcosine0.712uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine0.712uMWM47 LCT tumor
Reversed phase POSITIVE ION MODESarcosine0.716uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine0.731uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine0.735uMA375 LCT tumor
Reversed phase POSITIVE ION MODESarcosine0.759uMWM47 LCT tumor
Reversed phase POSITIVE ION MODESarcosine0.77uMWM47 LCT tumor
Reversed phase POSITIVE ION MODESarcosine0.772uMA375 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine0.774uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine0.783uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine0.788uMWM47 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine0.797uMWM47 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine0.825uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine0.848uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODESarcosine0.863uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine0.866uMWM3311 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine0.868uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine0.871uMWM47 LCT tumor
Reversed phase POSITIVE ION MODESarcosine0.88uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine0.882uMA375 LCT plasma
Reversed phase POSITIVE ION MODESarcosine0.886uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODESarcosine0.888uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine0.902uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine0.902uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine0.91uMA375 LCT plasma
Reversed phase POSITIVE ION MODESarcosine0.913uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine0.917uMA375 LCT tumor
Reversed phase POSITIVE ION MODESarcosine0.917uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine0.927uMA375 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine0.936uMA375 LCT tumor
Reversed phase POSITIVE ION MODESarcosine0.936uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine0.943uMA375 LCT plasma
Reversed phase POSITIVE ION MODESarcosine0.943uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine0.945uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine0.949uMWM47 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine0.963uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine0.969uMWM47 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.007uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.026uMA375 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.032uMA375 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.037uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine1.04uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.04uMWM47 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.046uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODESarcosine1.073uMA375 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine1.076uMA375 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.076uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.104uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.106uMWM3311 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.108uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.11uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODESarcosine1.115uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.125uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.128uMWM3000 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine1.138uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine1.147uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.158uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.159uMWM3311 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.159uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.169uMA375 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.169uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.17uMWM47 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.18uMA375 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.181uMWM3311 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.181uMWM47 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.183uMA375 LCT tumor
Reversed phase POSITIVE ION MODESarcosine1.191uMA375 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.192uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.223uMA375 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.226uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.237uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.237uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.245uMA375 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.248uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.248uMWM47 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.259uMWM47 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.267uMA375 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.277uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.281uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.284uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine1.288uMA375 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.294uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine1.299uMA375 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.304uMWM47 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.31uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.31uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.31uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.321uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.33uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODESarcosine1.332uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.342uMA375 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.342uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.359uMWM3311 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.382uMWM47 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.385uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine1.393uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.396uMA375 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.396uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.404uMWM3311 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.407uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.413uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine1.429uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.44uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.448uMWM47 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.468uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODESarcosine1.472uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.477uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine1.482uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.483uMA375 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.493uMWM47 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.494uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.526uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.541uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine1.549uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.559uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.56uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODESarcosine1.569uMA375 LCT tumor
Reversed phase POSITIVE ION MODESarcosine1.57uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.571uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.571uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.582uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.587uMA375 LCT tumor
Reversed phase POSITIVE ION MODESarcosine1.602uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.602uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.602uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.602uMWM3311 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine1.604uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.604uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.604uMWM47 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.612uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODESarcosine1.613uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.645uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.651uMWM3000 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine1.651uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine1.653uMWM3311 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine1.661uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine1.661uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine1.667uMA375 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.673uMWM3311 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine1.689uMA375 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.7uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.706uMA375 LCT tumor
Reversed phase POSITIVE ION MODESarcosine1.706uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODESarcosine1.716uMA375 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine1.721uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.727uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.734uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine1.734uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine1.761uMA375 LCT tumor
Reversed phase POSITIVE ION MODESarcosine1.765uMWM3311 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine1.775uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.78uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODESarcosine1.796uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODESarcosine1.806uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODESarcosine1.816uMWM3311 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.827uMWM47 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.844uMA375 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine1.844uMA375 LCT tumor
Reversed phase POSITIVE ION MODESarcosine1.861uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODESarcosine1.867uMWM3311 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine1.894uMA375 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.894uMWM3311 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.894uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODESarcosine1.908uMWM3311 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine1.908uMWM3311 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine1.918uMWM3311 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine1.936uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine1.949uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODESarcosine1.949uMWM3311 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine1.949uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODESarcosine1.954uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESarcosine1.99uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODESarcosine2.01uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODESarcosine2.028uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODESarcosine2.055uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODESarcosine2.064uMA375 CTRL tumor
Reversed phase POSITIVE ION MODESarcosine2.068uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODESarcosine2.071uMWM3311 CTRL tumor

Return to search page
  logo